Editorial Expression of Concern for the Research Article, “Inhibition of Chk2 promotes neuroprotection, axon regeneration, and functional recovery after CNS injury,” by Taylor et al.

Related coverage

• American Association for the Advancement of Science (AAAS) · Jun 11, 2026 Editorial Expression of Concern on 2024 Research Article “Durably reducing conspiracy beliefs through dialogues with AI”

  The Science journal has issued an Editorial Expression of Concern regarding a 2024 Research Article on using dialogues with AI to reduce conspiracy beliefs. The authors reported inconsistencies in their analysis pipeline and dataset, which affected the reproducibility of their results.

• Biochar Editorial Office, Shenyang Agricultural University · Jan 6, 2026 Building a global scientific community: Biological Diversity Journal announces dual recruitment of Editorial Board and Youth Editorial Board members

  The journal Biological Diversity is seeking experts in various disciplines to address the global biodiversity crisis. The editorial board will comprise senior scholars, while the youth editorial board will include early-career researchers. The dual structure aims to combine strategic wisdom and innovative energy.

• BMJ Group · May 4, 2024 Expression of concern placed on research paper: Efficacy of psilocybin for treating symptoms of depression

  A systematic review of psilocybin for treating symptoms of depression has been placed under expression of concern by The BMJ due to a methodological concern related to an error in the calculation of standardized mean differences. This may have resulted in overestimated benefits of psilocybin treatment.

• University of Seville · May 3, 2024 The key role of Galectin-3 in brain tumour development

  Researchers at the University of Seville discovered Galectin-3's crucial role in brain tumour progression, finding its inhibition significantly reduces glioblastoma size and brain metastases. Inhibition promotes pro-inflammatory markers and reverses immunosuppressive biomarkers, leading to improved outcomes.

• University of Cincinnati · Oct 23, 2025 What will stroke care look like in 2050?

  In a new Stroke article, Dr. Joseph Broderick predicts stroke care advancements by 2050, with a focus on patient-wearable diagnosis tools and AI-driven treatments for ischemic and hemorrhagic strokes. Researchers will overcome the challenge of neuroprotection and develop smaller, safer clot removal devices.

• Xia & He Publishing Inc. · Jun 19, 2024 TIMP-1 promotes expression of MCP-1 and macrophage migration by inducing Fli-1 in experimental liver fibrosis

  This study found that TIMP-1 induces the expression of transcription factor Fli-1, which elevates MCP-1 expression and promotes hepatic macrophage recruitment. siRNA-TIMP-1 alleviated liver fibrosis by reducing macrophage migration and MCP-1 expression.